ArticleFrontiers in genetics2020

Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders.

Evgenia Sklirou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.